Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Barry

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Breast (Edinburgh, Scotland)|July 5, 2017
Trial designs and results supporting treatment de-escalation and escalationMeredith M Regan, William T Barry
Current Medical Research and Opinion|May 21, 2009
Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002Frank G Bottone, William T Barry
Clinical and Translational Science|January 4, 2012
Statistical considerations for analysis of microarray experimentsKouros Owzar, William T Barry, Sin-Ho Jung
JAMA Oncology|June 30, 2018
Database Selection and Heterogeneity-More Details, More Credibility-ReplyRomualdo Barroso-Sousa, William T Barry, Sara M Tolaney
Biostatistics (Oxford, England)|February 23, 2013
Empirical pathway analysis, without permutationYi-Hui Zhou, William T Barry, Fred A Wright
Bioinformatics (Oxford, England)|January 14, 2005
Significance analysis of functional categories in gene expression studies: a structured permutation approachWilliam T Barry, Andrew B Nobel, Fred A Wright
Biometrics|February 18, 2017
Bayesian response-adaptive designs for basket trialsSteffen Ventz, William T Barry, Giovanni Parmigiani, et al.
Cancer Investigation|September 30, 2010
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic featuresJoseph Geradts, Sarah M Bean, Rex C Bentley, et al.
Journal of the National Cancer Institute|January 1, 2016
ResponseJennifer A Ligibel, Eric Winer, Clifford A Hudis, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
Using optical spectroscopy to longitudinally monitor physiological changes within solid tumorsKarthik Vishwanath, Hong Yuan, William T Barry, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Breast (Edinburgh, Scotland)|July 5, 2017
Trial designs and results supporting treatment de-escalation and escalationMeredith M Regan, William T Barry
Current Medical Research and Opinion|May 21, 2009
Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002Frank G Bottone, William T Barry
Clinical and Translational Science|January 4, 2012
Statistical considerations for analysis of microarray experimentsKouros Owzar, William T Barry, Sin-Ho Jung
JAMA Oncology|June 30, 2018
Database Selection and Heterogeneity-More Details, More Credibility-ReplyRomualdo Barroso-Sousa, William T Barry, Sara M Tolaney
Biostatistics (Oxford, England)|February 23, 2013
Empirical pathway analysis, without permutationYi-Hui Zhou, William T Barry, Fred A Wright
Bioinformatics (Oxford, England)|January 14, 2005
Significance analysis of functional categories in gene expression studies: a structured permutation approachWilliam T Barry, Andrew B Nobel, Fred A Wright
Biometrics|February 18, 2017
Bayesian response-adaptive designs for basket trialsSteffen Ventz, William T Barry, Giovanni Parmigiani, et al.
Cancer Investigation|September 30, 2010
The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic featuresJoseph Geradts, Sarah M Bean, Rex C Bentley, et al.
Journal of the National Cancer Institute|January 1, 2016
ResponseJennifer A Ligibel, Eric Winer, Clifford A Hudis, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
Using optical spectroscopy to longitudinally monitor physiological changes within solid tumorsKarthik Vishwanath, Hong Yuan, William T Barry, et al.
Pageof 13